[ad_1]
Ms. Esponnette said she thanked women at tech start-ups for saying how they felt.
Lola Priego, 30, founder of Base, which offers home blood and saliva tests processed in traditional labs, said she’s heard of Theranos comparisons at least once a week. He said the testimonials come directly or indirectly from potential partners, consultants, investors, clients and reporters.
He said he understands the need for skepticism as new healthcare companies need to be looked at critically to prevent malpractice. Oftentimes, comparisons stalled after people learned that Base was working with Quest Diagnostics, a multinational company, to analyze their tests.
“But the added bias and skepticism is difficult to overcome,” said Ms. Priego.
The biggest blow came from a science consultant Ms Priego says she tried to hire in 2019. The consultant took the meeting only to say that bringing technology to healthcare is hurting the industry, just like Theranos. This caused Ms. Priego to question whether she could hire consultants of the quality she had hoped for.
“It was pretty frustrating,” he said. It has since hired six advisors.
Verge Genomics in July, three-year partnership Ms. Zhang said they are working with pharmaceutical giant Eli Lilly to work on drugs to treat amyotrophic lateral sclerosis, or ALS. The company also published an article about its methods in a scientific journal last year, and it hired a chief science officer this year.
Ms. Zhang said it was a relief to have something to show those in doubt.
“The most fragile part of the company is the earliest stage where you have to buy the people, the vision and the idea,” he said. Thinking about Ms. Holmes and Theranos, she added, “This is where such associations can really be harmful and reduce the potential.”
[ad_2]
Source link